Skip to main content

Table 4 Accuracy of the SSEP and EEG malignant patterns, status myoclonus, NSE > 60 µg/ml and combinations for prediction of poor outcome

From: SSEP N20 and P25 amplitudes predict poor and good neurologic outcomes after cardiac arrest

  Se(%) Sp(%) FPR(%)
N20-baseline < 0,35 µV 35 (31–39) 100 (100–100) 0 (0–0)
N20-baseline < 0,88 µV 50 (44–56) 94 (92–97) 6 (3–8)
N20–P25 < 0,56 µV 50 (44–56) 100 (100–100) 0 (0–0)
N20–P25 < 1 µV 66 (60–72) 93 (90–96) 7 (4–10)
Status myoclonus 56 (51–62) 94 (92–97) 6 (3–8)
Day 3 NSE peak > 60 µg/ml 25 (20–31) 93 (90–96) 7 (4–10)
Malignant EEG 50 (44–56) 89 (85–92) 11 (8–15)
N20-baseline < 0,88 µV + NSE > 60 µg/ml 36 (31–41) 100 (100–100) 0 (0–0)
N20–P25 < 1 µV + NSE > 60 µg/ml 44 (38–49) 100 (100–100) 0 (0–0)
Bilaterally absent N20 SSEP 30* (25–35) 100 (100–100) 0 (0–0)
N20-baseline < 0.88 µV or N20 bilaterally absent 47 (41–52) 94 (92–97) 6 (3–8)
N20–P25 < 1 µV or N20 bilaterally absent 58* (52–63) 94 (92–97) 6 (3–8)
  1. *p = 0.002